Daily Archives: June 9, 2022
NICE Guideline: Gout diagnosis and management.
9 Jun, 2022 | 11:35h | UTCGout: diagnosis and management – National Institute for Health and Care Excellence
Study shows a person’s height impacts their risk of multiple diseases.
9 Jun, 2022 | 11:34h | UTCNews Release: A person’s height impacts their risk of multiple diseases – Public Library of Science
Original Study: A multi-population phenome-wide association study of genetically-predicted height in the Million Veteran Program – PLOS Genetics
CDC Report: Pediatric melatonin ingestions in the US.
9 Jun, 2022 | 11:32h | UTCPediatric Melatonin Ingestions — United States, 2012–2021 – Morbidity and Mortality Weekly Report
Commentaries:
Thousands of kids are getting sick from downing melatonin pills – NPR
Melatonin poisoning reports are up in kids, study says – Associated Press
Melatonin Overdoses Among Kids Are Up 530%, New Research Finds – TIME
Reports of melatonin poisoning in kids have increased 530% since 2012 – Yahoo News
Commentary on Twitter
New MMWR describes a 530% increase in pediatric melatonin ingestions reported to US poison control over the last decade; the largest increase occurred during the pandemic. https://t.co/SwJqTRG4s9 pic.twitter.com/AUxBrGX0Hj
— MMWR (@CDCMMWR) June 3, 2022
[News release – not published yet] Women not being routinely informed that a common anesthetic may lessen contraception effectiveness, doctors warn.
9 Jun, 2022 | 11:31h | UTCCommentary: Women in UK ‘seldom’ told drug used in surgery can impede contraception – The Guardian
Review: Deprescribing in palliative cancer care.
9 Jun, 2022 | 11:28h | UTCDeprescribing in Palliative Cancer Care – Life
Screening every five years safe for women who test negative for HPV, study confirms.
9 Jun, 2022 | 11:26h | UTCNews Release: Screening every five years safe for women who test negative for HPV, study confirms – King’s College London
Editorial: HPV screening for cervical cancer is reaching maturity – The BMJ
Related WHO Guidance:
News release: New recommendations for screening and treatment to prevent cervical cancer – World Health Organization
Related USPSTF Guidance: Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement – JAMA
Covid-19: US hospitals continued to perform unnecessary surgeries during pandemic.
9 Jun, 2022 | 11:22h | UTCCovid-19: US hospitals continued to perform unnecessary surgeries during pandemic – The BMJ
Original Report: Lown Institute. Hospital overuse during covid. 17 May 2022
Sex differences in clinical characteristics, management strategies, and outcomes of STEMI With COVID-19.
9 Jun, 2022 | 11:24h | UTCEditorial: STEMIs and a Closer Look at MINOCA During the COVID-19 Pandemic – JSCAI
Video: Conversations in Interventional Cardiology: NACMI Registry
Commentary: Mystery MINOCA? Many COVID STEMIs Have No Culprit Lesion – TCTMD
Management of sleep disorders among children and adolescents with neurodevelopmental disorders: A practical guide for clinicians.
9 Jun, 2022 | 11:21h | UTC
Consensus Statement: Assessment of foot alignment and function for ambulatory children with cerebral palsy.
9 Jun, 2022 | 10:59h | UTC
Role of diet in stroke incidence: an umbrella review of meta-analyses of prospective observational studies.
9 Jun, 2022 | 10:57h | UTC
M-A: Effects of diet on the outcomes of rheumatic and musculoskeletal diseases.
9 Jun, 2022 | 10:48h | UTCNews Release: Diet unlikely to ease progression of osteoarthritis, rheumatoid arthritis – BMJ
Migraine history tied to higher risk for adverse pregnancy outcomes.
9 Jun, 2022 | 10:49h | UTCMigraine History Tied to Higher Risk for Adverse Pregnancy Outcomes – HealthDay
RCT: Short-term effectiveness of high-load compared with low-load strengthening exercise on self-reported function in patients with hypermobile shoulders.
9 Jun, 2022 | 10:44h | UTC
Commentary on Twitter
? LATEST #OriginalResearch
⚠️ Hypermobility spectrum disorder and shoulder symptoms
Are high-load strengthening exercises more effective at improving shoulder function than low-load⁉️
NEW #OpenAccess randomised controlled trial ?
➡️ https://t.co/qQd8dDCdyW pic.twitter.com/jLyI3WxYRq
— British Journal of Sports Medicine (BJSM) (@BJSM_BMJ) June 4, 2022
Study shows that excessively high BMI is also associated with type 1 diabetes—not just the type 2.
9 Jun, 2022 | 10:40h | UTCNews Release: Study shows that excessively high BMI is also associated with type 1 diabetes—not just the type 2 – Diabetologia
Original Article: Obesity in late adolescence and incident type 1 diabetes in young adulthood – Diabetologia
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study.
9 Jun, 2022 | 10:42h | UTC
Commentary on Twitter (thread – click for more)
Global impact of hospital facilities on patient outcomes after cancer surgery from @globalsurg 3, published in @LancetGH
For every 100 #cancer operations, one to three early surgical deaths could be saved with improvements to hospital resources worldwidehttps://t.co/Qiv5dSZPzb pic.twitter.com/EbSInePjI4
— Steve Knight (@sr_knight1) May 30, 2022
Under a Creative Commons Attribution (CC BY 4.0) license
Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis.
9 Jun, 2022 | 10:36h | UTCSensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis – Eye
See Special Series: Research Methodology for the Ophthalmologist – Eye
Systematic Review: Evidence-based perioperative diagnosis and management of pulmonary embolism.
9 Jun, 2022 | 10:34h | UTC
Cohort Study: Long-term quality of life in patients with breast cancer after breast conservation vs mastectomy and reconstruction.
9 Jun, 2022 | 10:30h | UTCLong-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction – JAMA Surgery (link to abstract – $ for full-text)
Commentaries:
Long-Term QOL Examined for Surgical Choices in Breast Cancer – HealthDay
Commentary on Twitter
Survey of #breastcancer survivors after treatment found:
1. Breast satisfaction and physical well-being similar with lumpectomy+rads or mastectomy+reconstruction (no rads)
2. Psychosocial well-being and sexual well-being better with lumpectomy+rads https://t.co/tPh9Pt4gYx— JAMA Surgery (@JAMASurgery) April 14, 2022
Guidance for the interpretation of continual cuffless blood pressure data for the diagnosis and management of hypertension.
9 Jun, 2022 | 10:28h | UTC
Predictors of recurrent stroke after embolic stroke of undetermined source.
9 Jun, 2022 | 10:32h | UTC
RCT: Furmonertinib vs. gefitinib as first-line therapy for patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer.
9 Jun, 2022 | 10:25h | UTCFurmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study – The Lancet Respiratory Medicine (link to abstract – $ for full-text)
Systematic Review: N-Acetylcysteine for the management of non-acetaminophen drug-induced liver injury in adults.
9 Jun, 2022 | 10:27h | UTC
RCT: Abiraterone and Olaparib for metastatic castration-resistant prostate cancer.
9 Jun, 2022 | 10:21h | UTCAbiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer – NEJM Evidence
Commentary on Twitter
Combination treatment with abiraterone and olaparib increased progression-free survival regardless of homologous recombination repair gene mutation status in patients with metastatic castration-resistant #ProstateCancer treated in the first-line setting. https://t.co/CAUDF2ZErG pic.twitter.com/YARZa8AUXJ
— NEJM Evidence (@NEJMEvidence) June 3, 2022
RCT: Tremelimumab plus Durvalumab in unresectable hepatocellular carcinoma.
9 Jun, 2022 | 10:24h | UTCTremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma – NEJM Evidence
Commentary on Twitter
Durvalumab plus a single dose of tremelimumab increased overall survival by just over 2.5 months in patients with unresectable hepatocellular carcinoma who had not received previous systemic therapy. Read more about the HIMALAYA trial by @GABOUALFA et al.: https://t.co/8d2qp54OLt pic.twitter.com/AA1RlSEP2a
— NEJM Evidence (@NEJMEvidence) June 6, 2022